RHUMBLINE ADVISERS - CHINOOK THERAPEUTICS INC ownership

CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 139 filers reported holding CHINOOK THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of CHINOOK THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$3,428,677
+181024.0%
89,242
+9.1%
0.00%
+100.0%
Q1 2023$1,893
-10.9%
81,771
+0.8%
0.00%
-33.3%
Q4 2022$2,125
-99.9%
81,093
+5.7%
0.00%
+50.0%
Q3 2022$1,508,000
+36.0%
76,711
+21.0%
0.00%0.0%
Q2 2022$1,109,000
+35.1%
63,397
+26.3%
0.00%
+100.0%
Q1 2022$821,000
+9.9%
50,184
+9.5%
0.00%0.0%
Q4 2021$747,000
+42.6%
45,822
+11.5%
0.00%0.0%
Q3 2021$524,000
-5.8%
41,083
+4.3%
0.00%0.0%
Q2 2021$556,000
+123.3%
39,388
+145.4%
0.00%
Q1 2021$249,000
-6.7%
16,048
-4.6%
0.00%
Q4 2020$267,00016,8180.00%
Other shareholders
CHINOOK THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Parallel Advisors, LLC 5$00.00%
View complete list of CHINOOK THERAPEUTICS INC shareholders